Order Entry
Northern Ireland
ContactUsLinkComponent
Human recombinant cGAS (from E. coli)
Human recombinant cGAS (from E. coli)
Catalog # CAYM25001-100
Supplier:  Cayman Chemical
CAS Number:  
undefined
Human recombinant cGAS (from E. coli)
Catalog # CAYM25001-100
Supplier:  Cayman Chemical
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Pk:
    100 µG
  • Conjugation:
    Unconjugated
  • Enzyme type:
    Recombinant
  • Source:
    E. coli
  • Species:
    Human
  • Storage conditions:
    –80 °C
  • Shipping conditions:
    –80 °C, dry ice
  • Enzyme name:
    cGAS
  • Enzyme synonyms:
    C6orf150, 2'3'-cGAMP Synthease, cGAMP Synthase, h-cGAS, Cyclic GMP-AMP Synthase, Mab-21 domain containing protein 1, MB21D1
  • Purity:
    ≥90% estimated by SDS-PAGE
  • Molecular weight:
    44,6 kDa
  • Formulation:
    50 mM HEPES, pH 8,0, 150 mM sodium chloride, 1 mM DTT, and 10% glycerol

Specifications

About this item

  • UniProt: Q8N884

Cyclic GMP-AMP (cGAMP) synthase (cGAS) (161-522) is a truncated form of cGAS (Item No. 22810) that contains the nucleotidyltransferase and Mab21 domains. cGAS is a nucleotidyltransferase located in the cytosol that acts as a cytosolic DNA sensor to detect foreign DNA from microbial pathogens as part of the innate immune response. Upon binding to cytosolic DNA, cGAS produces the cyclic dinucleotide second messenger cGAMP, which activates stimulator of interferon genes (STING), leading to activation of the type I interferon (IFN) pathway. In vitro, fibroblasts, macrophages, and dendritic cells isolated from cGAS knockout (cGAS-/-) mice do not produce type I IFNs following DNA transfection or DNA virus infection. Similarly, cells containing a frame-shift mutation in the cGAS locus fail to mount an immune response to HIV and other retroviruses. In vivo, cGAS-/- mice infected with herpes simplex virus 1 (HSV-1) have lower levels of IFN-α and IFN-β, shorter survival times, and higher post-mortem levels of HSV-1 in the brain.

Used for: Innate Immunity, Infectious Disease, Intracellular Signalling